arcadia group stock price

A Luxury Fashion E-commerce Pure-Play, Datadog (NASDAQ:DDOG) Is Coming Back To Earth, Get Ready To Buy Some, 3 Restaurant Stocks Delivering Strong Results, Moderna (NASDAQ:MRNA) Makes Moves on Drug Gains, A Make Or Break Moment For Nikola (NASDAQ:NKLA) Investors, Go Grocery Outlet (NYSE:GO) Is A Mid-Cap Growth Story With Legs, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, MERCK Kommanditgesellschaft auf Aktien (MKGAF), Receive Analysts' Upgrades and Downgrades Daily. Get short term trading ideas from the MarketBeat Idea Engine. Why not be the first to send us your thoughts, Vote “Outperform” if you believe ACAD will outperform the S&P 500 over the long term. There are currently 1 hold rating and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Arcadia stock / share price, financials, funding rounds, investors and more at Craft. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Discover the under-the-radar stock that is taking the infant formula market vegan! Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ACADIA Pharmaceuticals in the last year. He added: "It's a cleverly timed deal by Philip Green. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Bhs billionaire Philip Green's bid for Topshop group Arcadia drew to a victorious close today after the company's board agreed to accept his £770 million takeover approach © American Consumer News, LLC dba MarketBeat® 2010-2020. Arcadia Group Brands offers its products to customers worldwide. ACADIA Pharmaceuticals' stock was trading at $36.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Company insiders that own ACADIA Pharmaceuticals stock include Austin D Kim, Bros Advisors Lp Baker, Elena Ridloff, Eric Alejandro Miller, James M Daly, Laura Brege, Michael J Yang, Srdjan R Stankovic and Stephen Davis. View institutional ownership trends for ACADIA Pharmaceuticals. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. We are no longer accepting comments on this article. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. ACADIA Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021. London: Pub installs phone on bar so customers can order drinks, Police officers appear to take down man near Edmonton Green, Bob Stewart tells harrowing story of Ballykelly bombing, Body of rapper Mo3 lies on Dallas highway after he was shot dead, Onlooker screams as man waves 'gun' outside window in Leicestershire, Police swoop on village and fire rubber bullets to take down man, Students hang banner from Manchester tower in protest, Body language clues that reveal Jeffrey Epstein's deception, An inside look at Naples Covid ward with 'corpse' on bathroom floor, Robert Jenrick refuses to comment on the resignation of Lee Cain, See how the controversial Stonehenge road tunnel would look like, Chinese engineer builds colossal 2,618ft long bridge on steep cliff. Bhs billionaire Philip Green's bid for Topshop group Arcadia drew to a victorious close today after the company's board agreed to accept his £770 million takeover approach. In the past three months, ACADIA Pharmaceuticals insiders have sold more of their company's stock than they have bought. The P/E ratio of ACADIA Pharmaceuticals is -29.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Arcadia said the 408p per share deal represented fair value to shareholders and recommended they accept the offer, which will see chief executive Stuart Rose pocket £25 million for less than two years work. ACADIA Pharmaceuticals has only been the subject of 2 research reports in the past 90 days. View our earnings forecast for ACADIA Pharmaceuticals. This gold stock should be on your radar when the price of gold bounces back.document.write(''); ACADIA Pharmaceuticals has received a consensus rating of Buy. 70 Berners Street Nick Bubb, retail analyst at SG Securities, said he was disappointed by Arcadia's decision and believed the board had been rattled by the falling stock market. ACADIA Pharmaceuticals updated its FY 2020 Arcadia annual revenue was £1.82 b in FY 2018. Want to see which stocks are moving? ACADIA Pharmaceuticals has a market capitalization of $8.05 billion and generates $339.08 million in revenue each year. He is expected to have to fork out a total of £900 million for Arcadia once management share options are taken into account and a bonus interim dividend of 4p per share is paid to Arcadia's shareholders. View which stocks have been most impacted by COVID-19. Sign-up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Vroom (NASDAQ:VRM) Stalls Out, Is It Time To Get On Board? The biopharmaceutical company can be reached via phone at 858-558-2871 or via email at [email protected]. Only 27.70% of the stock of ACADIA Pharmaceuticals is held by insiders. United Kingdom. ACADIA Pharmaceuticals has a P/B Ratio of 11.15. Learn about financial terms, types of investments, trading strategies and more. See what's happening in the market right now with MarketBeat's real-time news feed. Find the latest Arcadia Biosciences, Inc. (RKDA) stock quote, history, news and other vital information to help you with your stock trading and investing. The uncertain outlook for the high street and the economy is thought to have played a key role in swaying the Arcadia board during an emergency meeting last night. You may vote once every thirty days. He is expected to leave the enlarged business at Christmas and is likely to be at the centre of fevered speculation about his future. 16 brokers have issued 12-month target prices for ACADIA Pharmaceuticals' stock. Why a career in adult social care could be the... Fury as MPs blow £10,000 on sketch of Elizabeth Tower covered in scaffolding to commemorate bungled... or debate this issue live on our message boards. Combined turnover at the enlarged group will spiral to nearly £3 billion a year with close to 2,000 stores and 45,000 staff. ACADIA Pharmaceuticals' stock is owned by a number of retail and institutional investors. Billionaire scientist behind Pfizer and BioNTech's breakthrough Covid-19 vaccine claims it will 'bash the... Face masks can trigger bouts of ECZEMA in people with sensitive skin and allergies, study warns. Onboard the Caribbean coronavirus cruise: Pictures show mask-wearing staff and people consigned to their... RICHARD LITTLEJOHN: The Force is with you? ACADIA Pharmaceuticals employs 570 workers across the globe. View … ACADIA Pharmaceuticals does not have a long track record of dividend growth. Since then, ACAD stock has increased by 31.7% and is now trading at $48.56. Find the latest ACADIA Pharmaceuticals Inc. (ACAD) stock quote, history, news and other vital information to help you with your stock trading and investing. Export data to Excel for your own analysis. The biopharmaceutical company reported ($0.54) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.38) by $0.16. Receive a free world-class investing education from MarketBeat. Fundamental company data provided by Morningstar and Zacks Investment Research. Mr Rose, who has rejuvenated Arcadia since taking over in November 2000, played down his windfall and added: "We have done a good job for shareholders, they have had a good ride and should be very pleased.". All rights reserved. This suggests a possible upside of 18.6% from the stock's current price. Top institutional shareholders include BlackRock Inc. (4.54%), State Street Corp (1.70%), First Trust Advisors LP (1.09%), JPMorgan Chase & Co. (0.55%), Thrivent Financial for Lutherans (0.49%) and Neuberger Berman Group LLC (0.24%). View all competitors. He overcame the embarrassment of hearing the head office of his key backer and 20% Arcadia shareholder, Icelandic group Baugur, had been raided by police and after lengthy talks this week decided to press on alone. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Part of the Daily Mail, The Mail on Sunday & Metro Media Group. Since then, ACAD shares have increased by 10.9% and is now trading at $50.61. Company profile page for Arcadia Group Brands Ltd including stock price, company news, press releases, executives, board members, and contact information The biopharmaceutical company earns $-235,260,000.00 in net income (profit) each year or ($1.60) on an earnings per share basis. The Company provides dresses, tops, knitwear, jackets, blazers, coats, jeans, shorts, skirts, bags, leggings, boots, shoes, tees, shirts and ties, pajamas, sweaters, suits, sports coats, lingerie, and socks. Learn more. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ACADIA Pharmaceuticals' stock was trading at $45.64 on November 3rd, 2020 when the U.S. presidential election occured and Joe Biden was elected president. Richard Perks, analyst at Mintel Retail Intelligence, said: "People see Mr Green as a wheeler dealer but if you look at his record he's a pretty good retailer as well. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. View analyst ratings for ACADIA Pharmaceuticals. Elderly motorist crashes SIX times in one minute as he spins around street smashing into three cars and... Singleton reveals how lockdown has RUINED dating because men have 'let themselves go', harass women in the... A lack of energy, low mood and weakened immunity! Please log in to your account or sign up in order to add this asset to your watchlist. Specifically, they have bought $0.00 in company stock and sold $628,875.00 in company stock. Analysts said the deal marked another coup for Mr Green, who has transformed Bhs into an estimated £1 billion business after buying the group for just £200 million from Storehouse two years' ago.